Results 231 to 240 of about 66,826 (280)

Short‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and NMA

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 646-657, April 2026.
A meta‐analysis was conducted comparing the efficacy of biologics for the treatment of hidradenitis suppurativa (HS) for 12–16 weeks. Based on the SUCRA, bimekizumab was ranked the most efficacious treatment compared with secukinumab and adalimumab for all assessed efficacy outcomes, positioning it as the best treatment across biologic‐naïve and ...
Haley B. Naik   +9 more
wiley   +1 more source

Mid-childhood acne conglobata successfully treated with adalimumab. [PDF]

open access: yesJAAD Case Rep
Vidal González A   +5 more
europepmc   +1 more source

Savings from biosimilars and Medicare formulary access. [PDF]

open access: yesHealth Aff Sch
Axelsen K, Courmier D, Bai G, Maini L.
europepmc   +1 more source

Engagement and retention with remote monitoring in psoriasis: Findings from the mySkin study

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page e274-e277, April 2026.
Weiyu Ye   +22 more
wiley   +1 more source

Long‐term safety and efficacy in paediatric psoriasis: Remaining challenges

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 4, Page 558-559, April 2026.
Catherine Droitcourt, Ninon Le Goaziou
wiley   +1 more source

Home - About - Disclaimer - Privacy